The global sales pharma blister packaging machines market are estimated to be worth USD 2.2 billion in 2021 and are anticipated to reach a value of USD 2.9 billion by 2031. Sales are projected to rise at a CAGR of 2.8% over the forecast period between 2021 and 2031. The revenue generated by pharma blister packaging machines in 2020 was USD 2.1 billion.
The demand for reasonable, trustworthy, and quality packaging solutions in the pharmaceutical industry because of which the Pharma blister packaging machines market is exhibiting peak growth. Blister packaging machines protect, preserve, and present pharmaceutical products such as tablets, capsules, and other solid dose forms.
The burgeoning pharmaceutical production across the world, combined with increased demand for OTC and prescription medications, would continue to fuel the demand in the advanced blister packaging machines. Blister packaging machines ensure that pharmaceutical products are packed correctly and safely for the purpose of maintaining their integrity and prolonging shelf life.
The advancements in the area of biopharmaceuticals and biologics have strengthened the demand for advanced blister packaging machines since they require special packaging in order to maintain stability and efficacy. These machines will handle complex packaging applications and ensure sensitive biopharmaceutical products are protected.
Global Pharma Blister Packaging Machines Market Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2020 | USD 2.1 billion |
| Estimated Size, 2021 | USD 2.2 billion |
| Projected Size, 2031 | USD 2.9 billion |
| Value-based CAGR (2021 to 2031) | 2.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Pharma blister packaging machines are used to pack unit-dose packaging for capsules, gels, tablets, syringes, vials and throat lozenges. These machines typically use a 3-step process for packaging, which includes forming, sealing, and perforating & cutting respectively.
Forming uses thermoforming or cold-forming to make the product-specific packaging. Sealing is lidding and closing the product packaging using heat sealing or cold sealing, and the last step perforating & cutting uses precision die cutter to shape the packaging.
Blister packaging is tamper-proof and is relatively less expensive than foil packaging and plastic packaging used in the pharmaceutical sector. Also, single-unit consumption and hygiene of the products are the main factors that are responsible for the growth of the pharma blister packaging machines market during the forecast period.
High performance and productivity equipment designed with plug-in expansions, better flexibility and application over numerous materials are taking the market by storm. These features not only help manufacturers create better products but also help them with mass customized blister packaging.
The pharma blister packaging machines market is expected to develop at a high pace due to ongoing innovations and technological improvements.
Principal Consultant
Robotic integration and total customization are a few of the features that are expected to shape the market for pharma blister packaging machines. Transfer lines, machine learning and artificial intelligence are expected to carry out disruptive changes in the market. The introduction of new technologies and scientific breakthroughs play an important role in reshaping the pharma blister packaging machines market.
Advance motion control, modular software design and touch-sensitive built-in hardware are few factors that are reshaping the market for pharma blister packaging machines.
Other than these factors, digital counter inputs, embedded USB programming and HMI connectivity in machines are few other aspects that are rapidly influencing machine design and capabilities.
Every technological machine and equipment become obsolete with time. Companies incur additional costs due to the inevitable need for replacing their pharma blister packaging machines with the latest technologies. This leads to the shrinking of ROI and affects profit margins.
It could be avoided only by pre-planning and readiness to accept the changes in technology over time with rapid technological advancement, especially in the pharma blister packaging machines.
Constant technological changes have also led to an increase in company expenses on an individual’s training. Additionally, the company’s time and efforts are also spent on ensuring that its employees learn how to operate advanced models of pharma blister packaging machines. These factors might hinder the demand for new pharma blister packaging machines in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players operating in the pharma blister packaging machines market are Heino Ilsemann GmbH
Major players operating in the Asian market are
Key players are investing in technological upgradation and usage of better machines to enhance their production capacity in the market. New players are entering the market due to enormous growth opportunities due to pandemic that has led to an increasing demand in healthcare and pharmaceutical sector.
Heino Ilsemann GmbH launched the BS-300, a new compact and sophisticated blister packaging machine that enhances adaptability while occupying minimal space. This machine is designed to meet the specific needs of the pharmaceutical industry with a focus on efficiency and space-saving.
Germany is an automation-centric and highly progressing nation in Europe. Machine & Equipment (M&E) industry is one of the most lucrative and second-largest industries in the country. Technological development and high exports are the factors for the sector growth in the country.
According to the insights provided by Germany Trade & Invest, USD 6.9 bn has been spent on research and development of machines and equipment in the country during the period 2015 to 2017. Machine & Equipment (M&E) industry stands in the first position based on the degree of innovation in Germany.
Germany provides advanced technology development and excellent improvement to current state-of-art facilities in pharma blister packaging machines and is expected to remain a key player in the market.
Explore Packaging Insights
View Reports
Pharma Blister Packaging Machines Market
